Leveraging Novel Liquid Biopsy Technology to Accelerate Translational Research: Circulating Free DNA 5-hydroxymethylcytosine Profiling in Patients with Pancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTA-TATE
Time: 2:50 pm
day: Day Two Track B
Details:
- The use of circulating free DNA and its epigenomic status to infer tumor gene expression
- Insights into the mechanism of action of radioligand therapy, a targeted radioactive treatment for cancer
- Leveraging epigenomic status in blood samples to identify predictive biomarker candidates
